Impact BioMedical Celebrates Patent for 3F™ Technology
Impact BioMedical Announces New Patent for 3F™ Technology
Impact BioMedical Inc. (“IBO”) is excited to share that the US Patent and Trademark Office has granted U.S. Patent No. 11,985,973, titled “Insect Repelling Composition,” which is part of IBO’s innovative 3F™ technology platform.
Expanding the Patent Portfolio
This new patent complements IBO’s previously issued U.S. Patent No. 11,246,310. Both patents focus on unique compositions and formulations derived from plants and their fragrances, which serve as a natural barrier against insects, potentially lowering bites and landings in outdoor settings. The patents are set to expire in February 2039 and April 2040 respectively, providing IBO with a robust proprietary landscape in the field of insect repellents.
Commitment to Innovation in Healthcare
IBO’s expanding 3F™ patent portfolio features various compositions aimed at insect repellent and anti-microbial applications, not only in the United States but also in several international markets. This release underscores IBO’s dedication to innovation within human healthcare, specifically regarding unmet needs. The compositions are specifically designed to interfere with the olfactory receptors of insects, potentially rendering humans less detectable by these pests.
Potential Applications of 3F™ Technology
The multifunctionality of this technology opens avenues for its use as a repellent against mosquitoes and other insects. Moreover, it can be integrated into a variety of consumer products like shampoos, detergents, or lotions, enhancing their effectiveness at repelling insects.
Market Relevance of Natural Insect Repellents
According to the World Health Organization, around 17% of all infectious diseases globally are linked to vector-borne pathogens. The 3F™ insect repellent technology presents an innovative opportunity to enjoy outdoor activities without the concern of insect interference by utilizing a purely natural solution. This opens up significant market potential worldwide.
CEO Insights on the Patent Issuance
Following the notification of the patent issuance, IBO CEO Frank D. Heuszel expressed enthusiasm about the milestone. He stated, “This is another demonstration of success with our business model delivering new unique proprietary technology with the potential to address unmet needs in human healthcare. We are now accelerating discussions with potential partners to move 3F™ rapidly towards the market in the US and other countries worldwide.”
About Impact BioMedical, Inc.
Impact BioMedical Inc. identifies, confirms, and patents exceptional sciences and technologies destined for groundbreaking advancements in biopharmaceutical and consumer healthcare sectors. The company engages collaboratively with external partners through research initiatives, licensing agreements, co-development projects, joint ventures, and other strategic relationships.
Frequently Asked Questions
What is the significance of the U.S. Patent No. 11,985,973?
The patent secures IBO's innovative insect-repellent formulation under its 3F™ technology, enhancing its protection portfolio.
How does IBO's technology work?
3F™ technology alters insects' sensory perceptions, making humans virtually undetectable in natural settings.
What are the potential applications of this technology?
It could be used as a human insect repellent as well as incorporated into various consumer products like lotions and shampoos.
Why is the 3F™ insect repellent important?
It offers a natural alternative to traditional insect repellents, addressing global health concerns related to vector-borne diseases.
What role does IBO play in healthcare?
IBO focuses on discovering and developing technological solutions to meet crucial healthcare needs, promoting better health standards.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Elon Musk's $1 Million Daily Giveaway for Constitutional Support
- Embracing Technology to Revive Jiangxi's Cultural Heritage
- Key Insights for Xiao-I Corp. Investors Amid Legal Action
- Tesla Confirms High Efficiency of Inductive Charging for Cybercab
- Exploring High-Yield Investments for Steady Income Growth
- Important Class Action Update for Sage Therapeutics Investors
- Investor Alert: Key October Deadline for STMicroelectronics Case
- Investing in Dividend Stocks: A Guide for Retirement Planning
- Transformative Shift at Advance Auto Parts Promises Growth
- Investing in High-Yield Dividend Stocks for Steady Income
Recent Articles
- Exciting Expansion: Floor & Decor Opens Four New Locations
- Biodexa Pharmaceuticals Reveals Detailed Interim Results
- Upcoming Dexcom Q3 Earnings Conference Call Scheduled
- Fortress Biotech Engages Investors in Upcoming Conferences
- CSG Systems to Host Earnings Call for Q3 2024 Insights
- Reborn Coffee Expands Global Footprint with New Thailand Locations
- ColoBarn Partners with IvedaAI™ to Elevate Security Standards
- Yoshiharu Global Co. Expands into Korean BBQ Market
- Tempus and Takeda Collaborate for Enhanced Cancer Treatment Insights
- EXL Unveils Advanced LLM for Insurance Powered by NVIDIA
- OSI Systems Secures $27 Million for Cargo Inspection Service
- Stellantis Celebrates Exceptional Suppliers at Annual Awards
- Wearables Market Set for Growth with Varied Category Trends
- AITX Expands RIO™ Security Solutions with New Order
- Forge Global Introduces Innovative Forge Price for Investments
- Rising Apartment Supply Leads to Decrease in Asking Rents
- Alivia Analytics Welcomes Manny Fernandez as SVP of Government Solutions
- Upcoming Auction Insights for FirstEnergy's Default Service Program
- Addressing Manager Stress: A Call for Workplace Transformation
- Guggenheim Treasury Service's Groundbreaking Digital Commercial Paper
- LightPath Technologies Receives Major Defense Production Order
- cove.tool's New Book Aims at Transforming Built Environment
- AdTech Holding Achieves Great Place to Work Certification
- Amerant Bancorp Inc. Unveils Attractive Stock Offering Strategy
- Essential Permitting Tips for Homeowners After Hurricane Helene
- Princeton TMX Recognized as a Top Innovator in FreightTech
- SysAid Celebrates Recognition in Gartner Hype Cycle 2024 Reports
- Maximizing Returns: How to Generate Income from Costco Stock
- Finvi Partners with Divinity Software to Enhance Velosidy Efforts
- GITAI USA Moves to Larger HQ, Boosts Space Robotics Production
- Insights from CNBC's Final Trades: Key Stock Picks
- Unlocking the Mysteries of Precognition: Insights from Jon Taylor
- Discover These 3 Undervalued Materials Stocks to Watch
- Cascadia Windows & Doors Sets New Standards with EPDs
- Gulf Energy Information Joins Forces with Chempute Software
- Delaware LIVE News Enhances Structure for Local Coverage Growth
- Revolutionizing Financial Education with Vanguard AI 4.0
- Raising Awareness on Foster Care Housing Challenges Nationwide
- Engaging Discussions Await at 2025 CONNECTIONS™ Conferences
- Short Shorts Film Festival & Asia 2024 Autumn Screening Launch
- Empowering Women: SeeHer's Groundbreaking Campaign Launch
- Looma Secures $10 Million Funding to Enhance Store Media
- Researchers Discover New Drug Potential to Combat Aging
- AbbVie Reports Positive Phase 3 Trial Results for Tavapadon
- NaaS Technology Forms Strategic Alliance with IM Motors for EV Charging
- PTC Therapeutics Advances Huntington's Treatment with FDA's Support
- Mizuho Securities Projects Strong Performance for Accenture
- Accenture's Strategic Moves Spark Confidence Among Analysts
- BMO Capital Adjusts Ubisoft Target But Remains Positive
- Growth Momentum and Economic Stimulus Drive Market Trends